DRAFT PPV28 Pricing Categories 06-11-2026.pdf
PDF 93 KB Posted
- Solicitation number
- 36E79726Q0003
- Issued by
-
Department of Veterans Affairs
About this file
This is a draft pricing document for the PPV (Pharmaceutical Pricing and Volume) 2028 Distribution Fees structure. The document establishes six product categories with corresponding distribution fee structures, each offering both FASTPAY and NET30 payment terms.
The six categories are: (1) Ultra Expensive products with Wholesale Acquisition Cost (WAC) prices of $30,000 or greater; (2) GLP-1s, defined as non-ultra-expensive injectable products requiring refrigeration with mechanisms of action involving glucagon-like peptide receptor agonists, dual agonists, triple agonists, or amylin receptor agonists; (3) Specialty medications treating chronic, complex, or rare diseases with minimum four of five characteristics including list prices exceeding $3,000, specialist initiation/maintenance, special supply chain handling, non-traditional distribution channels, or significant side effects requiring additional monitoring; (4) Over-the-counter medications safe for consumer self-use without prescription and FDA-regulated; (5) VA FSS, all other VA/DLA national contracts, and medical surgical items and devices with FDA National Drug Codes or National Reimbursement Codes, including dietary supplements, blood-glucose monitoring units, and in-vitro diagnostics on Federal Supply Schedule Group 65, Part VII; and (6) WBPG ANDA generics priced based on Wholesale Acquisition Cost with FDA abbreviated new drug applications. The document provides definitional parameters for each category to enable proper product classification and fee application.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36E79726Q0003 0001.docx | DOCX document | |
| DRAFT PPV28 SOW 06-11-2026.pdf | ||
| DRAFT PPV28 Definitions 06-11-2026.pdf | ||
| 36E79726Q0003.docx | DOCX document | |
| DRAFT PPV28 Definitions 6-11-2026.pdf | ||
| DRAFT PPV28 Pricing Categories 6-11-2026.pdf | ||
| DRAFT PPV28 SOW 6-11-2026.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
DRAFT PPV 2028 Distribution Fees
Description Distribution Fee
1. Ultra Expensive, FASTPAY
1. Ultra Expensive, NET30
2. GLP-1s, FASTPAY
2. GLP-1s, NET30
3. Specialty, FASTPAY
3. Specialty, NET30
4. OTC, FASTPAY
4. OTC, NET30
5. FSS, all other and national contracts to include med-surg, FASTPAY
5. FSS, all other and national contracts to include med-surg, NET30
6. WBPG ANDA, FASTPAY
6. WBPG ANDA, NET30
1. Ultra Expensive is defined as a WAC price greater than or equal to $30,000.00.
2. GLP-1s are products not ultra expensive that are:
a. Injectable and
b. Require refrigeration and
c. Have a mechanism of action, either alone or in combination with, glucagon-like peptide (GLP-1) receptor agonists or dual agonists (e.g., GIP/GLP-1) or triple agonists (e.g. GIP/GLP-1/Glucagon Receptor Agonist) or amylin receptor agonists
3. Specialty is defined as medications that are not ultra expensive or GLP-1s which treat chronic, complex or rare diseases, and which have a minimum of four out of five additional characteristics related to the distribution, care delivery and/or cost of the medicines. These five characteristics include: list price in excess of $3,000 initiated/maintained by a specialist, requiring special handling in the supply chain, distributed through non-traditional channels, or medication has significant side-effects that require additional monitoring of therapy and/or disease requires additional monitoring of therapy.
4. OTC means over the counter medications that can be purchased without a prescription, are safe and effective for consumer self-use when taken as directed and regulated by the FDA.
5. VA FSS, all other and VA/DLA national contracts to include medical surgical items and medical devices that are packaged, labeled, and commercialized like drug product and therefore receive a FDA National Drug Code (NDC) or National
Reimbursement Code (NRC). This category also includes, dietary supplements, Blood-glucose Monitoring Units and Consumables including Miscellaneous items included on a National Contract or Federal Supply Schedule Group 65, Part VII, In- Vitro Diagnostics, Reagents, Test Kits, and Test Sets.
6. WBPG ANDA are defined as generics prices based on their Wholesale Acquisition Cost with an FDA abbreviated new drug application.
File details come from the government source that posted it. Updated .